The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/EC4F9DA5.svg?ark=w1%2F20260526%2FEC4F9DA5&value=id)](https://nobleid.org/work/w1/20260526/EC4F9DA5)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors